COMP <GO>
LQDA vs UNH // REVENUE GROWTH (YOY)
Liquidia Corporation (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: LQDA 4
— UNH 10
▲ REVENUE GROWTH (YOY) LEADER: LQDA
LAST: $45.06 (+0.16%) • MKT CAP: $4.03B
revenue-growth
180.00%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
revenue-growth
6.46%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDA | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.60% | 11.47% | -24.07 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.99% | 6.48% | -7.47 | UNH | /fcf-yield <GO> |
| Operating Margin | -32.50% | 4.82% | -37.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | -43.50% | 3.14% | -46.64 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 180.00% | 6.46% | +173.54 | LQDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.33 | 3.12 | +3.21 | LQDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.74% | -0.14 | LQDA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 56.0 | -3.52 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.33 | +0.57 | LQDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 17.1x | +3.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.03B | $364.66B | -$360.63B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDA REV | UNH REV | LQDA GROSS % | UNH GROSS % | LQDA FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.3M | $447.57B | 44.0% | 88.7% | -$40.0M | $16.07B |
| FY 2024 | $14.0M | $400.28B | 58.0% | 88.3% | -$98.4M | $20.70B |
| FY 2023 | $17.5M | $371.62B | 44.0% | 89.6% | -$42.4M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
UNH // BETA 0.33